Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 928-842-2 | CAS number: 1184648-08-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral, LD50, rat [(R)-2-(4-hydroxyphenoxy)-propanoic acid] > 2000 mg/kg bw (Lheritier 1988)
Inhalation, 4 hours, LC50 [(R)-2-(4-hydroxyphenoxy)-propanoic acid] > 1.84 mg/L (Young 1996)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute toxicity of potassium (R)-2-(4-hydroxyphenoxy)propionate, (CAS 1184648-08-5) was determined by read-across from acute toxicity studies conducted with the free acid, namely (R)-2-(4-hydroxyphenoxy)propanoic acid (CAS 94050-90 -5).
Oral:
Only a single oral toxicity study conducted according to guideline OECD 401 and under GLP is available for the source substance, (R)-2-(4-hydroxyphenoxy)-propanoic acid (CAS 94050-90-5). The study is considered to be relevant, reliable (Klimisch 1) and adequate for the purposes of risk assessment, classification and labelling. The LD50 in male and female rats was determined to be >2000 mg/kg bw, since no mortality, clinical signs, or macropathological findings were observed in the limit test with the source substance, the free acid (R)-2-(4-hydroxyphenoxy)-propanoic acid.
The acute oral toxicity of the target substance propanoic acid, 2-(4-hydroxyphenoxy)-, potassium salt (2R) (CAS 1184648-08-5) is determined by read-across from the limit test with the free acid. The analogue approach is based on the facts that source and target contain the identical molecular structure and the same functional groups (except the K+ counterion), form a pH-dependent equilibrium, and the salt is rapidly converted to the free acid under the acidic conditions in the stomach. Upon neutralization in the duodenum (with a large excess of sodium ions), source and target become fully indistinguishable in their bioavailability and metabolic fate.
The only difference, the presence of equimolar quantities of potassium ions in the target substance, is expected to have no toxicological consequences, since the quantity of K+ administered with a limit test dose (2000 mg/kg bw) of the target substance amounts to only 26% of a conservative estimate for the oral LD50 of potassium ions, derived from KCl data.
As a conclusion, the acute oral toxicity of propanoic acid, 2-(4-hydroxyphenoxy)-, potassium salt (2R) is estimated to be >= 2000 mg/kg bw.
Inhalation:
Only a single inhalation toxicity study conducted according to guideline OECD 403 and under GLP is available for the source substance, (R)-2-(4-hydroxyphenoxy)-propanoic acid (CAS 94050-90-5). The study is considered to be relevant, reliable (Klimisch 1) and adequate for the purposes of risk assessment, classification and labelling. The LC50 in male and female rats upon 4-hour nose-only exposure to the test substance dust was determined to be > 1.84 +/- 0.31 mg/L air (analytical, highest achievable concentration), since no mortality and no clinical symptoms were observed with the source substance, the free acid (R)-2-(4-hydroxyphenoxy)-propanoic acid.
The acute inhalation toxicity of the target substance propanoic acid, 2-(4-hydroxyphenoxy)-, potassium salt (2R) (CAS 1184648-08-5) is determined by read-across from the limit inhalation test with the free acid. The analogue approach is based on the facts that source and target contain the identical molecular structure and the same functional groups (except the K+ counterion), form a pH-dependent equilibrium, and both are rapidly converted to the sodium salt in plasma (due to the large excess of sodium ions) after uptake via the lungs, which makes both substances indistinguishable in their bioavailability and metabolic fate.
The only difference, the presence of equimolar quantities of potassium ions in the target substance, is expected to have limited toxicological consequences, since the quantity of K+ administered per hour during inhalation of a limit concentration (5000 mg/m3 of the target substance) amounts to approx. 99% of a non-lethal intravenous and ca. 58% of a lethal intravenous K+ infusion rate determined for KCl.
As a conclusion, the acute inhalation LC50 of propanoic acid, 2-(4-hydroxyphenoxy)-, potassium salt (2R) is estimated to be > 1840 mg/m3.
For Classification purposes it should also be considered that there is no sign of any clinical effect at the highest technically achievable concentration in the respective test so that it is highly likely that the real LC50 level is even higher than the limit concentration for classification purposes. This is supported by another LC50 measurement reported in UBE Industries Ltd., Tokyo, Japan (2002): Safety Data Sheet of R-HPPA (CAS 94050-90-5), Version 1, 2002/07/15 with LC50 > 5.2 mg/L (inh. rat). Based on these findings the substance is not classified due to acute inhalation toxicity.
Justification for classification or non-classification
Acute Oral Toxicity
The key value selected for the acute oral toxicity, LD50>2000mg/kg bw does not lead to classification, according to the criteria in Directive 2001/59/EC, Annex VI, 3.2.3.
The key value selected for the acute oral toxicity, LD50>2000mg/kg bw does not lead to classification, according to the criteria in Regulation (EC) No. 1272/2008, Annex I, Part 3, 3.1.2.
Acute Inhalation Toxicity
The key value selected for the acute oral toxicity, LD50 >1.84 mg/L bw together with other information provided as part of a weight of evidence does not lead to classification, according to the criteria in Directive 2001/59/EC, Annex VI, 3.2.3.
The key value selected for the acute oral toxicity, LD50 >1.84 mg/L bw together with other information provided as part of a weight of evedince does not lead to classification, according to the criteria in Regulation (EC) No. 1272/2008, Annex I, Part 3, 3.1.2.
Acute Dermal Toxicity
No experimental data are available which are suitable for the purposes of classification and labelling.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.